Literature DB >> 22241435

Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial.

E Blank1, N Willich, R Fietkau, W Popp, J Schaller-Steiner, H Sack, F Wenz.   

Abstract

BACKGROUND AND
PURPOSE: To conform to recommendations regarding the treatment of breast cancer, an estimation of costs and personnel to assure treatment is required. To date no recommendations based on real time measurements are available. The DEGRO (German Society of Radiation Oncology), therefore, initiated a prospective multicenter evaluation of core procedures of radiotherapy. In this analysis, the results regarding human resources and room occupation during the treatment of breast cancer are presented. PATIENTS AND METHODS: Three academic radiation oncology centers (Erlangen, Münster, Mannheim) prospectively documented their workflow and working time for all breast cancer patients from July-October 2008. Subsequently, a statistical analysis was performed.
RESULTS: The longest working time of physicians was the definition of the target volume and organs at risk (mean 33 min). Furthermore, physicians needed much time for general tasks, which included conversations. Physicists needed the most time for treatment planning and authorization (64 min), whereas technicians were mostly needed in day-to-day radiotherapy treatment (15 min, 31 min including verification). Despite significant differences in specific steps between centers, overall working times and room occupation were comparable and representative. Special procedures (intraoperative radiotherapy/multicatheter brachytherapy) required considerable amounts of additional working time of physicians and physicists.
CONCLUSION: In this prospective analysis, data of human resources and room occupation during treatment of breast cancer are presented for the first time. Each patient consumes about 12 h of human resources for treatment and 3.75 h for general tasks (physicians 4.7 h, physicists 1.8 h, and technicians 9.2 h).

Entities:  

Mesh:

Year:  2012        PMID: 22241435     DOI: 10.1007/s00066-011-0020-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  16 in total

1.  Costs of radiotherapy.

Authors:  Anders Norlund
Journal:  Acta Oncol       Date:  2003       Impact factor: 4.089

2.  [Breast Care Nurses - nursing experts for breast cancer care. A path to "Advanced Nursing Practice" in Germany?].

Authors:  Anja Gerlach; Regina Wiedemann
Journal:  Pflege       Date:  2010-12       Impact factor: 0.655

Review 3.  The cost of radiation therapy.

Authors:  Nicolas Paul Ploquin; Peter Brian Dunscombe
Journal:  Radiother Oncol       Date:  2008-01-30       Impact factor: 6.280

4.  Guidelines for International Breast Health and Cancer Control--Implementation. Introduction.

Authors:  Benjamin O Anderson; Sandra R Distelhorst
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

Review 5.  kV cone-beam CT-based IGRT: a clinical review.

Authors:  Judit Boda-Heggemann; Frank Lohr; Frederik Wenz; Michael Flentje; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

6.  Optimizing the quality of breast cancer care at certified german breast centers: a benchmarking analysis for 2003-2009 with a particular focus on the interdisciplinary specialty of radiation oncology.

Authors:  Sara Y Brucker; Markus Wallwiener; Rolf Kreienberg; Walter Jonat; Matthias W Beckmann; Michael Bamberg; Diethelm Wallwiener; Rainer Souchon
Journal:  Strahlenther Onkol       Date:  2011-01-21       Impact factor: 3.621

7.  Time management in radiation oncology: development and evaluation of a modular system based on the example of rectal cancer treatment. The DEGRO-QUIRO trial.

Authors:  R Fietkau; W Budach; N Zamboglou; H-J Thiel; H Sack; W Popp
Journal:  Strahlenther Onkol       Date:  2011-12-24       Impact factor: 3.621

8.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial.

Authors:  Wilfried Budach; Edwin Bölke; Rainer Fietkau; Andre Buchali; Thomas G Wendt; Wolfgang Popp; Christiane Matuschek; Horst Sack
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

9.  Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?

Authors:  P Boyle; A d'Onofrio; P Maisonneuve; G Severi; C Robertson; M Tubiana; U Veronesi
Journal:  Ann Oncol       Date:  2003-08       Impact factor: 32.976

10.  Survival for cancer patients in Europe.

Authors:  Arduino Verdecchia; Mariano Santaquilani; Milena Sant
Journal:  Ann Ist Super Sanita       Date:  2009       Impact factor: 1.663

View more
  16 in total

1.  Evaluation of time, attendance of medical staff and resources for radiotherapy in pediatric and adolescent patients. The DEGRO-QUIRO trial.

Authors:  Angelika Zabel-du Bois; Stefanie Milker-Zabel; Frank Bruns; Hans Christiansen; Iris Ernst; Normann Willich; Wolfgang Popp; Jürgen Debus; Horst Sack
Journal:  Strahlenther Onkol       Date:  2014-04-01       Impact factor: 3.621

2.  Time management in radiation oncology: evaluation of time, attendance of medical staff, and resources during radiotherapy for prostate cancer: the DEGRO-QUIRO trial.

Authors:  L Keilholz; J Willner; H-J Thiel; N Zamboglou; H Sack; W Popp
Journal:  Strahlenther Onkol       Date:  2013-10-16       Impact factor: 3.621

3.  Timing of radiotherapy following breast-conserving surgery: outcome of 1393 patients at a single institution.

Authors:  S Corradini; O M Niemoeller; M Niyazi; F Manapov; M Haerting; N Harbeck; C Belka; S Kahlert
Journal:  Strahlenther Onkol       Date:  2014-02-07       Impact factor: 3.621

4.  The QUIRO Study (assurance of quality and innovation in radiooncology): methodology, instruments and practices.

Authors:  J Dunst; N Willich; H Sack; R Engenhart-Cabillic; V Budach; W Popp
Journal:  Strahlenther Onkol       Date:  2014-01-11       Impact factor: 3.621

Review 5.  [Radiation therapy in patients with cardiac pacemakers or implantable cardioverter defibrillators. Interdisciplinary safety recommendations].

Authors:  M Dorenkamp; C Stromberger; C von Heymann; W Haverkamp; P Wust; M Roser
Journal:  Strahlenther Onkol       Date:  2012-11-11       Impact factor: 3.621

6.  Counseling cancer patients on complementary and alternative medicine. Background, theory, and implementation of nationwide counseling facilities.

Authors:  J Hübner; K Muenstedt; R Muecke; O Micke; C Stoll; U R Kleeberg; J Buentzel; G Dennert; F J Prott
Journal:  Strahlenther Onkol       Date:  2013-07-05       Impact factor: 3.621

7.  Protection of quality and innovation in radiation oncology: the prospective multicenter trial QUIRO of DEGRO: evaluation of time, attendance of medical staff, and resources during radiotherapy with tomotherapy.

Authors:  Cornelia Winkler; M N Duma; W Popp; H Sack; V Budach; M Molls; S Kampfer
Journal:  Strahlenther Onkol       Date:  2014-03-22       Impact factor: 3.621

8.  Radiotherapy infrastructure and human resources in Switzerland : Present status and projected computations for 2020.

Authors:  Niloy Ranjan Datta; Shaka Khan; Dietmar Marder; Daniel Zwahlen; Stephan Bodis
Journal:  Strahlenther Onkol       Date:  2016-07-25       Impact factor: 3.621

9.  Time evaluation of image-guided radiotherapy in patients with spinal bone metastases. A single-center study.

Authors:  H Rief; D Habermehl; K Schubert; J Debus; S E Combs
Journal:  Strahlenther Onkol       Date:  2014-01-16       Impact factor: 3.621

10.  Evaluation of the time required for overhead tasks performed by physicians, medical physicists, and technicians in radiation oncology institutions: the DEGRO-QUIRO study.

Authors:  Cornelia Sack; Horst Sack; Normann Willich; Wolfgang Popp
Journal:  Strahlenther Onkol       Date:  2014-09-23       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.